News
Eli Lilly (NYSE:LLY) on Sunday said that its drug Zepbound (tirzepatide) showed superior weight loss over Novo Nordisk's (NVO ...
2d
TipRanks on MSNEli Lilly’s Zepbound Defeats Novo Nordisk’s Wegovy Once AgainPreview in new tab Pharmaceutical giants Eli Lilly ($LLY) and Novo Nordisk ($NVO) are engaged in a head-to-head battle to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results